Expression and Characterization of Cysteine-Modified Variants of an Amino-Terminal Fragment of Bactericidal/Permeability-Increasing Protein
rBPI23is a biologically active, recombinant N-terminal fragment of human bactericidal/permeability-increasing protein (BPI). While rBPI23is readily purified from culture supernatants of Chinese hamster ovary (CHO)-K1 transfectants, it is heterogeneous, consisting of monomer and disulfide-linked dime...
Gespeichert in:
Veröffentlicht in: | Protein expression and purification 1996-08, Vol.8 (1), p.28-40 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 40 |
---|---|
container_issue | 1 |
container_start_page | 28 |
container_title | Protein expression and purification |
container_volume | 8 |
creator | Horwitz, Arnold H. Leigh, Scott D. Abrahamson, Susan Gazzano-Santoro, Hélène Liu, Pei-Syan Williams, Robert E. Carroll, Stephen F. Theofan, Georgia |
description | rBPI23is a biologically active, recombinant N-terminal fragment of human bactericidal/permeability-increasing protein (BPI). While rBPI23is readily purified from culture supernatants of Chinese hamster ovary (CHO)-K1 transfectants, it is heterogeneous, consisting of monomer and disulfide-linked dimer, characteristics due presumably to the presence of three cysteines within the molecule. We have examined the role of these cysteines in rBPI23expression, function, and dimer formation by mutating their codons to alanine (C132A), serine (C135S), or alanine (C175A) and expressing analogues of N-terminal fragments (“variants”) lacking one, two, or all three cysteines in permanently transfected CHO-K1 cells. We also expressed a variant in which serine 18 was changed to cysteine (S18C), as found in both bovine and rabbit BPI. The C132A variant was readily secreted and purified as a homogeneous, stable monomeric protein species. The C135S and S18C variants were produced as mixtures of monomer and dimer; the C135S variant was poorly secreted, difficult to purify, and unstable on storage. In contrast, the C175A variant and those lacking any two or all three cysteines were expressed but not secreted. Purified rBPI23and the C132A and S18C variants had comparable bactericidal and lipopolysaccharide (LPS) binding activities and were similarly effective at neutralizing LPS-induced tumor necrosis factor synthesis by THP-1 cells; the purified C135S variant lacked all activities. From these studies with CHO-K1 transfectants, we conclude that (i) cysteines 135 and 175 are both necessary for efficient secretion of a biologically active N-terminal BPI fragment, presumably through the formation of a disulfide bond, (ii) cysteine 132 is responsible for dimer formation, and (iii) only the C132A modification yields a stable, biologically active, N-terminal BPI fragment (designated rBPI21) that is free of dimeric species. |
doi_str_mv | 10.1006/prep.1996.0071 |
format | Article |
fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1006_prep_1996_0071</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1046592896900716</els_id><sourcerecordid>S1046592896900716</sourcerecordid><originalsourceid>FETCH-LOGICAL-c405t-83526eed7796f1176a6308137320f7e617840ae48879b27e3825ef2b3e49086c3</originalsourceid><addsrcrecordid>eNp1kEFOwzAQRS0EKqWwZYeUCyS1ncR2lqVqoVIRXRS2keNMilHiRHZAlCtwaWKlYsdqRvP__Bk9hG4JjgjGbN5Z6CKSZSzCmJMzNCU4YyGmPDv3fcLCNKPiEl05944xIQynEzQRglAR0yn6WX0NCc7p1gTSlMHyTVqperD6W_Z-2FbB8uh60AbCp7bUlYYyeJVWS9M7r0oTLBpt2nAPdqiyDtZWHhowvVfvxzClS1nPd4MDZKFr3R_DjVEWpNPmEOxs6w9co4tK1g5uTnWGXtar_fIx3D4_bJaLbagSnPahiFPKAErOM1YRwplkMRYk5jHFFQdGuEiwhEQInhWUQyxoChUtYkgyLJiKZygac5VtnbNQ5Z3VjbTHnODcQ8091NxDzT3UYeFuXOg-igbKP_uJ4qCLUYfh608NNndKg1FQaguqz8tW_xf9C1kyiAs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Expression and Characterization of Cysteine-Modified Variants of an Amino-Terminal Fragment of Bactericidal/Permeability-Increasing Protein</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Horwitz, Arnold H. ; Leigh, Scott D. ; Abrahamson, Susan ; Gazzano-Santoro, Hélène ; Liu, Pei-Syan ; Williams, Robert E. ; Carroll, Stephen F. ; Theofan, Georgia</creator><creatorcontrib>Horwitz, Arnold H. ; Leigh, Scott D. ; Abrahamson, Susan ; Gazzano-Santoro, Hélène ; Liu, Pei-Syan ; Williams, Robert E. ; Carroll, Stephen F. ; Theofan, Georgia</creatorcontrib><description>rBPI23is a biologically active, recombinant N-terminal fragment of human bactericidal/permeability-increasing protein (BPI). While rBPI23is readily purified from culture supernatants of Chinese hamster ovary (CHO)-K1 transfectants, it is heterogeneous, consisting of monomer and disulfide-linked dimer, characteristics due presumably to the presence of three cysteines within the molecule. We have examined the role of these cysteines in rBPI23expression, function, and dimer formation by mutating their codons to alanine (C132A), serine (C135S), or alanine (C175A) and expressing analogues of N-terminal fragments (“variants”) lacking one, two, or all three cysteines in permanently transfected CHO-K1 cells. We also expressed a variant in which serine 18 was changed to cysteine (S18C), as found in both bovine and rabbit BPI. The C132A variant was readily secreted and purified as a homogeneous, stable monomeric protein species. The C135S and S18C variants were produced as mixtures of monomer and dimer; the C135S variant was poorly secreted, difficult to purify, and unstable on storage. In contrast, the C175A variant and those lacking any two or all three cysteines were expressed but not secreted. Purified rBPI23and the C132A and S18C variants had comparable bactericidal and lipopolysaccharide (LPS) binding activities and were similarly effective at neutralizing LPS-induced tumor necrosis factor synthesis by THP-1 cells; the purified C135S variant lacked all activities. From these studies with CHO-K1 transfectants, we conclude that (i) cysteines 135 and 175 are both necessary for efficient secretion of a biologically active N-terminal BPI fragment, presumably through the formation of a disulfide bond, (ii) cysteine 132 is responsible for dimer formation, and (iii) only the C132A modification yields a stable, biologically active, N-terminal BPI fragment (designated rBPI21) that is free of dimeric species.</description><identifier>ISSN: 1046-5928</identifier><identifier>EISSN: 1096-0279</identifier><identifier>DOI: 10.1006/prep.1996.0071</identifier><identifier>PMID: 8812832</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Anti-Infective Agents - pharmacology ; Antimicrobial Cationic Peptides ; Binding, Competitive ; Blood Proteins - chemistry ; Blood Proteins - genetics ; Blood Proteins - isolation & purification ; Blotting, Northern ; Blotting, Western ; Carrier Proteins - metabolism ; CHO Cells ; Cricetinae ; Cysteine - genetics ; Cysteine - metabolism ; Disulfides - metabolism ; Electrophoresis, Polyacrylamide Gel ; Heat-Shock Proteins ; Humans ; Lipopolysaccharides - pharmacology ; Membrane Proteins ; Molecular Chaperones - metabolism ; Mutagenesis, Site-Directed - genetics ; Protein Conformation ; Protein Folding ; Recombinant Proteins - chemistry ; Recombinant Proteins - isolation & purification ; Recombinant Proteins - metabolism ; Sulfhydryl Compounds - metabolism ; Tumor Necrosis Factor-alpha - metabolism</subject><ispartof>Protein expression and purification, 1996-08, Vol.8 (1), p.28-40</ispartof><rights>1996 Academic Press</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c405t-83526eed7796f1176a6308137320f7e617840ae48879b27e3825ef2b3e49086c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/prep.1996.0071$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8812832$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Horwitz, Arnold H.</creatorcontrib><creatorcontrib>Leigh, Scott D.</creatorcontrib><creatorcontrib>Abrahamson, Susan</creatorcontrib><creatorcontrib>Gazzano-Santoro, Hélène</creatorcontrib><creatorcontrib>Liu, Pei-Syan</creatorcontrib><creatorcontrib>Williams, Robert E.</creatorcontrib><creatorcontrib>Carroll, Stephen F.</creatorcontrib><creatorcontrib>Theofan, Georgia</creatorcontrib><title>Expression and Characterization of Cysteine-Modified Variants of an Amino-Terminal Fragment of Bactericidal/Permeability-Increasing Protein</title><title>Protein expression and purification</title><addtitle>Protein Expr Purif</addtitle><description>rBPI23is a biologically active, recombinant N-terminal fragment of human bactericidal/permeability-increasing protein (BPI). While rBPI23is readily purified from culture supernatants of Chinese hamster ovary (CHO)-K1 transfectants, it is heterogeneous, consisting of monomer and disulfide-linked dimer, characteristics due presumably to the presence of three cysteines within the molecule. We have examined the role of these cysteines in rBPI23expression, function, and dimer formation by mutating their codons to alanine (C132A), serine (C135S), or alanine (C175A) and expressing analogues of N-terminal fragments (“variants”) lacking one, two, or all three cysteines in permanently transfected CHO-K1 cells. We also expressed a variant in which serine 18 was changed to cysteine (S18C), as found in both bovine and rabbit BPI. The C132A variant was readily secreted and purified as a homogeneous, stable monomeric protein species. The C135S and S18C variants were produced as mixtures of monomer and dimer; the C135S variant was poorly secreted, difficult to purify, and unstable on storage. In contrast, the C175A variant and those lacking any two or all three cysteines were expressed but not secreted. Purified rBPI23and the C132A and S18C variants had comparable bactericidal and lipopolysaccharide (LPS) binding activities and were similarly effective at neutralizing LPS-induced tumor necrosis factor synthesis by THP-1 cells; the purified C135S variant lacked all activities. From these studies with CHO-K1 transfectants, we conclude that (i) cysteines 135 and 175 are both necessary for efficient secretion of a biologically active N-terminal BPI fragment, presumably through the formation of a disulfide bond, (ii) cysteine 132 is responsible for dimer formation, and (iii) only the C132A modification yields a stable, biologically active, N-terminal BPI fragment (designated rBPI21) that is free of dimeric species.</description><subject>Animals</subject><subject>Anti-Infective Agents - pharmacology</subject><subject>Antimicrobial Cationic Peptides</subject><subject>Binding, Competitive</subject><subject>Blood Proteins - chemistry</subject><subject>Blood Proteins - genetics</subject><subject>Blood Proteins - isolation & purification</subject><subject>Blotting, Northern</subject><subject>Blotting, Western</subject><subject>Carrier Proteins - metabolism</subject><subject>CHO Cells</subject><subject>Cricetinae</subject><subject>Cysteine - genetics</subject><subject>Cysteine - metabolism</subject><subject>Disulfides - metabolism</subject><subject>Electrophoresis, Polyacrylamide Gel</subject><subject>Heat-Shock Proteins</subject><subject>Humans</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Membrane Proteins</subject><subject>Molecular Chaperones - metabolism</subject><subject>Mutagenesis, Site-Directed - genetics</subject><subject>Protein Conformation</subject><subject>Protein Folding</subject><subject>Recombinant Proteins - chemistry</subject><subject>Recombinant Proteins - isolation & purification</subject><subject>Recombinant Proteins - metabolism</subject><subject>Sulfhydryl Compounds - metabolism</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><issn>1046-5928</issn><issn>1096-0279</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEFOwzAQRS0EKqWwZYeUCyS1ncR2lqVqoVIRXRS2keNMilHiRHZAlCtwaWKlYsdqRvP__Bk9hG4JjgjGbN5Z6CKSZSzCmJMzNCU4YyGmPDv3fcLCNKPiEl05944xIQynEzQRglAR0yn6WX0NCc7p1gTSlMHyTVqperD6W_Z-2FbB8uh60AbCp7bUlYYyeJVWS9M7r0oTLBpt2nAPdqiyDtZWHhowvVfvxzClS1nPd4MDZKFr3R_DjVEWpNPmEOxs6w9co4tK1g5uTnWGXtar_fIx3D4_bJaLbagSnPahiFPKAErOM1YRwplkMRYk5jHFFQdGuEiwhEQInhWUQyxoChUtYkgyLJiKZygac5VtnbNQ5Z3VjbTHnODcQ8091NxDzT3UYeFuXOg-igbKP_uJ4qCLUYfh608NNndKg1FQaguqz8tW_xf9C1kyiAs</recordid><startdate>19960801</startdate><enddate>19960801</enddate><creator>Horwitz, Arnold H.</creator><creator>Leigh, Scott D.</creator><creator>Abrahamson, Susan</creator><creator>Gazzano-Santoro, Hélène</creator><creator>Liu, Pei-Syan</creator><creator>Williams, Robert E.</creator><creator>Carroll, Stephen F.</creator><creator>Theofan, Georgia</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19960801</creationdate><title>Expression and Characterization of Cysteine-Modified Variants of an Amino-Terminal Fragment of Bactericidal/Permeability-Increasing Protein</title><author>Horwitz, Arnold H. ; Leigh, Scott D. ; Abrahamson, Susan ; Gazzano-Santoro, Hélène ; Liu, Pei-Syan ; Williams, Robert E. ; Carroll, Stephen F. ; Theofan, Georgia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c405t-83526eed7796f1176a6308137320f7e617840ae48879b27e3825ef2b3e49086c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Animals</topic><topic>Anti-Infective Agents - pharmacology</topic><topic>Antimicrobial Cationic Peptides</topic><topic>Binding, Competitive</topic><topic>Blood Proteins - chemistry</topic><topic>Blood Proteins - genetics</topic><topic>Blood Proteins - isolation & purification</topic><topic>Blotting, Northern</topic><topic>Blotting, Western</topic><topic>Carrier Proteins - metabolism</topic><topic>CHO Cells</topic><topic>Cricetinae</topic><topic>Cysteine - genetics</topic><topic>Cysteine - metabolism</topic><topic>Disulfides - metabolism</topic><topic>Electrophoresis, Polyacrylamide Gel</topic><topic>Heat-Shock Proteins</topic><topic>Humans</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Membrane Proteins</topic><topic>Molecular Chaperones - metabolism</topic><topic>Mutagenesis, Site-Directed - genetics</topic><topic>Protein Conformation</topic><topic>Protein Folding</topic><topic>Recombinant Proteins - chemistry</topic><topic>Recombinant Proteins - isolation & purification</topic><topic>Recombinant Proteins - metabolism</topic><topic>Sulfhydryl Compounds - metabolism</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Horwitz, Arnold H.</creatorcontrib><creatorcontrib>Leigh, Scott D.</creatorcontrib><creatorcontrib>Abrahamson, Susan</creatorcontrib><creatorcontrib>Gazzano-Santoro, Hélène</creatorcontrib><creatorcontrib>Liu, Pei-Syan</creatorcontrib><creatorcontrib>Williams, Robert E.</creatorcontrib><creatorcontrib>Carroll, Stephen F.</creatorcontrib><creatorcontrib>Theofan, Georgia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Protein expression and purification</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Horwitz, Arnold H.</au><au>Leigh, Scott D.</au><au>Abrahamson, Susan</au><au>Gazzano-Santoro, Hélène</au><au>Liu, Pei-Syan</au><au>Williams, Robert E.</au><au>Carroll, Stephen F.</au><au>Theofan, Georgia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression and Characterization of Cysteine-Modified Variants of an Amino-Terminal Fragment of Bactericidal/Permeability-Increasing Protein</atitle><jtitle>Protein expression and purification</jtitle><addtitle>Protein Expr Purif</addtitle><date>1996-08-01</date><risdate>1996</risdate><volume>8</volume><issue>1</issue><spage>28</spage><epage>40</epage><pages>28-40</pages><issn>1046-5928</issn><eissn>1096-0279</eissn><abstract>rBPI23is a biologically active, recombinant N-terminal fragment of human bactericidal/permeability-increasing protein (BPI). While rBPI23is readily purified from culture supernatants of Chinese hamster ovary (CHO)-K1 transfectants, it is heterogeneous, consisting of monomer and disulfide-linked dimer, characteristics due presumably to the presence of three cysteines within the molecule. We have examined the role of these cysteines in rBPI23expression, function, and dimer formation by mutating their codons to alanine (C132A), serine (C135S), or alanine (C175A) and expressing analogues of N-terminal fragments (“variants”) lacking one, two, or all three cysteines in permanently transfected CHO-K1 cells. We also expressed a variant in which serine 18 was changed to cysteine (S18C), as found in both bovine and rabbit BPI. The C132A variant was readily secreted and purified as a homogeneous, stable monomeric protein species. The C135S and S18C variants were produced as mixtures of monomer and dimer; the C135S variant was poorly secreted, difficult to purify, and unstable on storage. In contrast, the C175A variant and those lacking any two or all three cysteines were expressed but not secreted. Purified rBPI23and the C132A and S18C variants had comparable bactericidal and lipopolysaccharide (LPS) binding activities and were similarly effective at neutralizing LPS-induced tumor necrosis factor synthesis by THP-1 cells; the purified C135S variant lacked all activities. From these studies with CHO-K1 transfectants, we conclude that (i) cysteines 135 and 175 are both necessary for efficient secretion of a biologically active N-terminal BPI fragment, presumably through the formation of a disulfide bond, (ii) cysteine 132 is responsible for dimer formation, and (iii) only the C132A modification yields a stable, biologically active, N-terminal BPI fragment (designated rBPI21) that is free of dimeric species.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>8812832</pmid><doi>10.1006/prep.1996.0071</doi><tpages>13</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1046-5928 |
ispartof | Protein expression and purification, 1996-08, Vol.8 (1), p.28-40 |
issn | 1046-5928 1096-0279 |
language | eng |
recordid | cdi_crossref_primary_10_1006_prep_1996_0071 |
source | Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE |
subjects | Animals Anti-Infective Agents - pharmacology Antimicrobial Cationic Peptides Binding, Competitive Blood Proteins - chemistry Blood Proteins - genetics Blood Proteins - isolation & purification Blotting, Northern Blotting, Western Carrier Proteins - metabolism CHO Cells Cricetinae Cysteine - genetics Cysteine - metabolism Disulfides - metabolism Electrophoresis, Polyacrylamide Gel Heat-Shock Proteins Humans Lipopolysaccharides - pharmacology Membrane Proteins Molecular Chaperones - metabolism Mutagenesis, Site-Directed - genetics Protein Conformation Protein Folding Recombinant Proteins - chemistry Recombinant Proteins - isolation & purification Recombinant Proteins - metabolism Sulfhydryl Compounds - metabolism Tumor Necrosis Factor-alpha - metabolism |
title | Expression and Characterization of Cysteine-Modified Variants of an Amino-Terminal Fragment of Bactericidal/Permeability-Increasing Protein |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T08%3A37%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20and%20Characterization%20of%20Cysteine-Modified%20Variants%20of%20an%20Amino-Terminal%20Fragment%20of%20Bactericidal/Permeability-Increasing%20Protein&rft.jtitle=Protein%20expression%20and%20purification&rft.au=Horwitz,%20Arnold%20H.&rft.date=1996-08-01&rft.volume=8&rft.issue=1&rft.spage=28&rft.epage=40&rft.pages=28-40&rft.issn=1046-5928&rft.eissn=1096-0279&rft_id=info:doi/10.1006/prep.1996.0071&rft_dat=%3Celsevier_cross%3ES1046592896900716%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/8812832&rft_els_id=S1046592896900716&rfr_iscdi=true |